MeSH D001859 - bone neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Zoledronic acid | Zoledronic acid Teva |  | 2012-08-16 |  |  |
| Zoledronic acid | Zoledronic acid Teva Generics |  | 2014-03-27 |  |  | |
| Zoledronic acid | Zoledronic acid Teva Pharma |  | 2012-08-15 |  |  | |
| Mylan | Zoledronic acid | Zoledronic Acid |  | 2013-03-04 |  |  |
| Zoledronic acid | Zoledronic acid Mylan |  | 2012-08-23 |  |  | |
| Sandoz | Zoledronic acid | Aclasta |  | 2005-04-15 |  |  |
| Zoledronic acid | Reclast | 2023-10-27 | 2007-04-16 |  |  | |
| Novartis | Zoledronic acid | Zometa | 2025-05-29 | 2001-08-20 |  |  |
| Pfizer | Zoledronic acid | Zoledronic Acid Hospira |  | 2012-11-19 |  |  |
| Dr Reddys Laboratories | Zoledronic acid | Zoledronic Acid |  | 2013-03-04 |  |  |
| Sun Pharmaceutical Industries | Zoledronic acid | Zoledronic Acid |  | 2013-03-04 |  |  |
| Apotex | Zoledronic acid | Zoledronic Acid |  | 2015-12-24 |  |  |
| Breckenridge Pharmaceutical | Zoledronic acid | Zoledronic Acid |  | 2013-03-04 |  |  |
| Hospira | Zoledronic acid | Zoledronic Acid |  | 2015-03-19 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
80%24/30
Phase 2
23%10/44
Phase 3
9%3/32
Approved: 1Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use